[Use of moxifloxacin in tuberculosis regimen in a French teaching hospital]

Med Mal Infect. 2010 Oct;40(10):568-73. doi: 10.1016/j.medmal.2010.04.004.
[Article in French]

Abstract

Objective: To evaluate retrospectively indications of moxifloxacin prescriptions in inpatients with tuberculosis in a referent teaching hospital.

Design: All patients hospitalized at Bichat-Claude Bernard hospital and who had an active tuberculosis disease with a tuberculosis regimen including moxifloxacin were included. Medical charts were retrospectively reviewed for all these patients over 21 months. Data collected were reasons for introduction of moxifloxacin in regimen.

Results: Out of the 23 patients included in the study, 13 of them had a recurrence of tuberculosis. Several reasons for introduction of moxifloxacin were recorded and one prescription can be associated with one or more reasons: an extra pulmonary tuberculosis or disseminated tuberculosis (16 cases), an intolerance to other anti-tuberculosis drugs (13 cases), a medical history of therapeutic failure or a proved or suspected drug-resistant Mycobacterium tuberculosis (12 cases) or to avoid drug interactions (two cases).

Conclusions: This retrospective study in our hospital highlights that drug-resistance was not the first reason for introduction of moxifloxacin in anti-tuberculosis regimen. One major indication was bad tolerance to other first-line regimen drugs. A better supervision of the moxifloxacin prescription in tuberculosis regimen is needed in order to limit its ecological impact.

MeSH terms

  • Adult
  • Aged
  • Antitubercular Agents / administration & dosage
  • Antitubercular Agents / therapeutic use*
  • Aza Compounds / administration & dosage
  • Aza Compounds / therapeutic use*
  • Comorbidity
  • Drug Prescriptions / statistics & numerical data
  • Drug Therapy, Combination
  • Drug Utilization
  • Female
  • Fluoroquinolones
  • France / epidemiology
  • HIV Infections / epidemiology
  • Hospitals, University / statistics & numerical data*
  • Humans
  • Male
  • Middle Aged
  • Moxifloxacin
  • Quinolines / administration & dosage
  • Quinolines / therapeutic use*
  • Recurrence
  • Retrospective Studies
  • Tuberculosis / drug therapy*
  • Tuberculosis / epidemiology
  • Young Adult

Substances

  • Antitubercular Agents
  • Aza Compounds
  • Fluoroquinolones
  • Quinolines
  • Moxifloxacin